The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview
Open accessAbstract
Matrix metalloproteinases (MMPs) are zinc dependent proteolytic metalloenzyme. MMP-9 is one of the most complex forms of matrix metalloproteinases. MMP-9 has the ability to degrade the extracellular matrix (ECM) components and has important role in the pathophysiological functions. Overexpression and dysregulation of MMP-9 is associated with various diseases. Thus, regulation and inhibition of MMP-9 is an important therapeutic approach for combating various diseases including cancer. Inhibitors of MMP-9 can be used as anticancer agents. Till date no selective MMP-9 inhibitors passed the clinical trials. In this review the structure, activation, function and inhibitors of MMP-9 are mainly focused. Some highly active and/or selective MMP-9 inhibitors have been discussed which may be helpful to explore the structural significance of MMP-9 inhibitors. This study may be useful to design new potent and selective MMP-9 inhibitors against cancer in future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Structure and function of matrix metalloproteinases and TIMPs
NAGASE, H., VISSE, R., & MURPHY, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.002 · Cited by 3,409
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Gialeli, C., Theocharis, A. D., & Karamanos, N. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07919.x · Cited by 1,607
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Jabłońska-Trypuć, A., Matejczyk, M., & Rosochacki, S. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1161620 · Cited by 1,042
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
Whittaker, M., Floyd, C. D., Brown, P., & Gearing, A. J. H. (1999) · Chemical Reviews · doi:10.1021/cr9804543 · Cited by 982
Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)
Van den Steen, P. E., Dubois, B., Nelissen, I., Rudd, P. M., Dwek, R. A., & Opdenakker, G. (2002) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230290771546 · Cited by 946
Matrix Metalloproteinase-2 Is an Interstitial Collagenase
Aimes, R. T., & Quigley, J. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.5872 · Cited by 944
Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hidalgo, M., & Eckhardt, S. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.178 · Cited by 798
Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
Huang, H. (2018) · Sensors · doi:10.3390/s18103249 · Cited by 739
Gelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes
Winer, A., Adams, S., & Mignatti, P. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0646 · Cited by 651
Matrix Metalloproteinase-9: Many Shades of Function in Cardiovascular Disease
Yabluchanskiy, A., Ma, Y., Iyer, R. P., Hall, M. E., & Lindsey, M. L. (2013) · Physiology · doi:10.1152/physiol.00029.2013 · Cited by 635
Ramos-DeSimone, N., Hahn-Dantona, E., Sipley, J., Nagase, H., French, D. L., & Quigley, J. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13066 · Cited by 591
Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models
Fanjul-Fernández, M., Folgueras, A. R., Cabrera, S., & López-Otín, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.07.004 · Cited by 582
Structure of Human Pro-Matrix Metalloproteinase-2: Activation Mechanism Revealed
Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G., & Tryggvason, K. (1999) · Science · doi:10.1126/science.284.5420.1667 · Cited by 540
Matrix metalloproteinase inhibitors
Wojtowicz-Praga, S. M., Dickson, R. B., & Hawkins, M. J. (1997) · Investigational New Drugs · doi:10.1023/a:1005722729132 · Cited by 518
Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas
Cathcart, J., Pulkoski-Gross, A., & Cao, J. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2014.12.002 · Cited by 504
Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase Activity: Role of Oxidative Stress
Uemura, S., Matsushita, H., Li, W., Glassford, A. J., Asagami, T., Lee, K.-H., Harrison, D. G., & Tsao, P. S. (2001) · Circulation Research · doi:10.1161/hh1201.092042 · Cited by 485
Wang, W., Schulze, C. J., Suarez-Pinzon, W. L., Dyck, J. R. B., Sawicki, G., & Schulz, R. (2002) · Circulation · doi:10.1161/01.cir.0000028818.33488.7b · Cited by 484
Matrix metalloproteinases: Fold and function of their catalytic domains
Tallant, C., Marrero, A., & Gomis-Rüth, F. X. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.003 · Cited by 463
Gu, Z., Cui, J., Brown, S., Fridman, R., Mobashery, S., Strongin, A. Y., & Lipton, S. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1563-05.2005 · Cited by 417
Membrane-type matrix metalloproteinases: Their functions and regulations
Itoh, Y. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.03.004 · Cited by 401
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia
Klein, G., Vellenga, E., Fraaije, M. W., Kamps, W. A., & de Bont, E. S. J. M. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.001 · Cited by 350
Jacobsen, J. A., Major Jourden, J. L., Miller, M. T., & Cohen, S. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.08.006 · Cited by 313
Experimental metastasis is suppressed in MMP-9-deficient mice
Itoh, T., Tanioka, M., Matsuda, H., Nishimoto, H., Yoshioka, T., Suzuki, R., & Uehira, M. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006603723759 · Cited by 308
Tamura, Y., Watanabe, F., Nakatani, T., Yasui, K., Fuji, M., Komurasaki, T., Tsuzuki, H., Maekawa, R., Yoshioka, T., Kawada, K., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9707582 · Cited by 284
Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs
Churg, A., Wang, R., Wang, X., Onnervik, P.-O., Thim, K., & Wright, J. L. (2007) · Thorax · doi:10.1136/thx.2006.068353 · Cited by 245
SHALINSKY, D. R., BREKKEN, J., ZOU, H., MCDERMOTT, C. D., FORSYTH, P., EDWARDS, D., MARGOSIAK, S., BENDER, S., TRUITT, G., WOOD, A., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07689.x · Cited by 239
Matrix metalloproteinases at cancer tumor–host interface
NOEL, A., JOST, M., & MAQUOI, E. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.05.011 · Cited by 239
Pruijt, J. F. M., Fibbe, W. E., Laterveer, L., Pieters, R. A., Lindley, I. J. D., Paemen, L., Masure, S., Willemze, R., & Opdenakker, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10863 · Cited by 228
Rao, B. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382115 · Cited by 221
The Design, Structure, and Therapeutic Application of Matrix Metalloproteinase Inhibitors
Skiles, J., Gonnella, N., & Jeng, A. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013373417 · Cited by 215
Marshall, D. C., Lyman, S. K., McCauley, S., Kovalenko, M., Spangler, R., Liu, C., Lee, M., O’Sullivan, C., Barry-Hamilton, V., Ghermazien, H., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127063 · Cited by 201
Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes
Toth, M., Chvyrkova, I., Bernardo, M. M., Hernandez-Barrantes, S., & Fridman, R. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01405-0 · Cited by 196
Sela-Passwell, N., Rosenblum, G., Shoham, T., & Sagi, I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.010 · Cited by 173
Khorsandi, K., Kianmehr, Z., hosseinmardi, Z., & Hosseinzadeh, R. (2020) · Cancer Cell International · doi:10.1186/s12935-020-1100-y · Cited by 165
Macaulay, V. M., O'Byrne, K. J., Saunders, M. P., et al. (1999) · PubMed · Cited by 161
Scannevin, R. H., Alexander, R., Haarlander, T. M., Burke, S. L., Singer, M., Huo, C., Zhang, Y.-M., Maguire, D., Spurlino, J., Deckman, I., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.806075 · Cited by 160
Matrix-metalloproteinase-9 is cleaved and activated by Cathepsin K
Christensen, J., & Shastri, V. P. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1284-8 · Cited by 159
Nguyen, T. T., Ding, D., Wolter, W. R., Pérez, R. L., Champion, M. M., Mahasenan, K. V., Hesek, D., Lee, M., Schroeder, V. A., Jones, J. I., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01005 · Cited by 155
Maurya, D. K., Nandakumar, N., & Devasagayam, T. P. A. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-004fr · Cited by 154
Matrix Metalloproteinase Inhibitors: Current Developments and Future Perspectives
Hoekstra, R., Eskens, F. A. L. M., & Verweij, J. (2001) · The Oncologist · doi:10.1634/theoncologist.6-5-415 · Cited by 154
Khandelwal, A., Lukáčová, V., Çömez, D., Kroll, D. M., Raha, S., & Baláž, Š. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049050v · Cited by 153
Flavonoid Antioxidant Silymarin and Skin Cancer
Singh, R. P., & Agarwal, R. (2002) · Antioxidants and Redox Signaling · doi:10.1089/15230860260220166 · Cited by 148
Pyrimidine-2,4,6-Triones: A New Effective and Selective Class of Matrix Metalloproteinase Inhibitors
Grams, F., Brandstetter, H., DAlò, S., Geppert, D., Krell, H., Leinert, H., Livi, V., Menta, E., Oliva, A., & Zimmermann, G. (2001) · Biological Chemistry · doi:10.1515/bc.2001.159 · Cited by 141
Ebihara, I., Nakamura, T., Shimada, N., & Koide, H. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70015-0 · Cited by 133
Monferran, S., Paupert, J., Dauvillier, S., Salles, B., & Muller, C. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600403 · Cited by 129
Brandstetter, H., Grams, F., Glitz, D., Lang, A., Huber, R., Bode, W., Krell, H., & Engh, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007475200 · Cited by 129
A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?
Vandenbroucke, R. E., Dejonckheere, E., & Libert, C. (2011) · European Respiratory Journal · doi:10.1183/09031936.00027411 · Cited by 127
Cancer Preventive Mechanismsof the Green Tea Polyphenol (-)-Epigallocatechin-3-gallate
Chen, L., & Zhang, H. (2007) · Molecules · doi:10.3390/12050946 · Cited by 127
Clinical studies with matrix metalloproteinase inhibitors
Brown, P. D. N. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01541.x · Cited by 126
Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development
Bronisz, E., & Kurkowska‐Jastrzębska, I. (2016) · Mediators of Inflammation · doi:10.1155/2016/7369020 · Cited by 114
Wada, C. K., Holms, J. H., Curtin, M. L., Dai, Y., Florjancic, A. S., Garland, R. B., Guo, Y. P., Heyman, H. R., Stacey, J. R., Steinman, D. H., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0103920 · Cited by 106
Matrix Metalloproteinases in Non-Neoplastic Disorders
Tokito, A., & Jougasaki, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071178 · Cited by 104
Becker, D. P., Barta, T. E., Bedell, L. J., Boehm, T. L., Bond, B. R., Carroll, J. N., Carron, C. P., DeCrescenzo, G. A., Easton, A. M., Freskos, J. N., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100669j · Cited by 101
Yamamoto, M., Tsujishita, H., Hori, N., Ohishi, Y., Inoue, S., Ikeda, S., & Okada, Y. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970404a · Cited by 101
New strategies for targeting matrix metalloproteinases.
Fields, G. B. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.002 · Cited by 98
Kiyama, R., Tamura, Y., Watanabe, F., Tsuzuki, H., Ohtani, M., & Yodo, M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980514x · Cited by 97
Martens, E., Leyssen, A., Aelst, I. V., Fiten, P., Piccard, H., Hu, J., Descamps, F. J., den Steen, P. E. V., Proost, P., Damme, J. V., et al. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.10.012 · Cited by 93
Saragusti, A. C., Ortega, M. G., Cabrera, J. L., Estrin, D. A., Marti, M. A., & Chiabrando, G. A. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.07.001 · Cited by 88
Adhikari, N., Amin, S. A., Trivedi, P., Jha, T., & Ghosh, B. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.081 · Cited by 87
Self-citationSantos, O., McDermott, C. D., Daniels, R., & Appelt, K. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018418725453 · Cited by 86
RYBAKOWSKI, J. K. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/904836 · Cited by 85
Gimeno, A., Beltrán‐Debón, R., Mulero, M., Pujadas, G., & García-Vallvé, S. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.07.013 · Cited by 81
Nuti, E., Cantelmo, A. R., Gallo, C., Bruno, A., Bassani, B., Camodeca, C., Tuccinardi, T., Vera, L., Orlandini, E., Nencetti, S., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00367 · Cited by 77
Liu, Y., Liu, H., Luo, X., Deng, J., Pan, Y., & Liang, H. (2015) · Tumor Biology · doi:10.1007/s13277-015-3077-z · Cited by 75
Zhang, C., & Kim, S. (2009) · Marine Drugs · doi:10.3390/md7020071 · Cited by 75
Amin, S. A., Adhikari, N., & Jha, T. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.002 · Cited by 74
Self-citationWagner, S., Breyholz, H., Law, M. P., Faust, A., Höltke, C., Schröer, S., Haufe, G., Levkau, B., Schober, O., Schäfers, M. A., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0708533 · Cited by 73
Halder, A. K., Mallick, S., Shikha, D., Saha, A., Saha, K. D., & Jha, T. (2015) · RSC Advances · doi:10.1039/c5ra12606a · Cited by 71
Self-citationAranapakam, V., Davis, J. M., Grosu, G. T., Baker, Ellingboe, J. W., Zask, A., Levin, J. I., Sandanayaka, V. P., Du, M. T., Skotnicki, J. S., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0205550 · Cited by 70
Avoiding spam in the proteolytic internet: Future strategies for anti-metastatic MMP inhibition
Krüger, A., Kates, R. E., & Edwards, D. R. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.09.016 · Cited by 70
Breyholz, H., Schäfers, M. A., Wagner, S., Höltke, C., Faust, A., Rabeneck, H., Levkau, B., Schober, O., & Kopka, K. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049145x · Cited by 68
Nyormoi, O., Mills, L., & Bar‐Eli, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401209 · Cited by 68
Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview
Adhikari, N., Mukherjee, A., Saha, A., & Jha, T. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.02.014 · Cited by 67
Self-citationKim, S., Kim, S. H., Hur, S. M., Lee, S.-K., Kim, W. W., Kim, J. S., Kim, J., Choe, J., Nam, S. J., Lee, J. E., et al. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.08.032 · Cited by 63
Adhikari, N., Halder, A. K., Mallick, S., Saha, A., Saha, K. D., & Jha, T. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.07.023 · Cited by 59
Self-citationSagi, I., Talmi-Frank, D., Arkadash, V., Papo, N., & Mohan, V. (2016) · Metalloproteinases In Medicine · doi:10.2147/mnm.s65143 · Cited by 59
Chen, Y., & Chang, L. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200167 · Cited by 56
Nuti, E., Panelli, L., Casalini, F., Avramova, S. I., Orlandini, E., Santamaria, S., Nencetti, S., Tuccinardi, T., Martinelli, A., Cercignani, G., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900335a · Cited by 56
X‐ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin
Dunten, P., Kammlott, U., Crowther, R. L., Levin, W., Foley, L. H., Wang, P., & Palermo, R. E. (2001) · Protein Science · doi:10.1110/ps.48401 · Cited by 56
Samartzis, E. P., Fink, D. A., Stucki, M., & Imesch, P. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0481-z · Cited by 52
N-Substituted homopiperazine barbiturates as gelatinase inhibitors
Wang, J., Medina, C., Radomski, M. W., & Gilmer, J. F. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.055 · Cited by 50
Hanessian, S., MacKay, D. B., & Moitessier, N. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010096n · Cited by 49
Hanessian, S., Moitessier, N., Gauchet, C., & Viau, M. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010097f · Cited by 45
Vandooren, J., Knoops, S., Buzzo, J. L. A., Boon, L., Martens, E., Opdenakker, G., & Kołaczkowska, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174853 · Cited by 45
Hugenberg, V., Breyholz, H., Riemann, B., Hermann, S., Schober, O., Schäfers, M. A., Gangadharmath, U. B., Mocharla, V. P., Kolb, H. C., Walsh, J. C., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300199g · Cited by 44
Thorsen, S. B., Christensen, S. L., Würtz, S. Ø., Lundberg, M., Nielsen, B. S., Vinther, L., Knowles, M., Gee, N., Fredriksson, S., Möller, S., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-598 · Cited by 44
Dour, G. L., Moroy, G., Rouffet, M., Bourguet, E., Guillaume, D. M., Decarme, M., Mourabit, H. E., Augé, F., Alix, A. J. P., Laronze, J., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.041 · Cited by 41
Baugh, M. D., Gavrilović, J., Davies, I. R., Hughes, D. A., & Sampson, M. (2003) · Cardiovascular Diabetology · doi:10.1186/1475-2840-2-3 · Cited by 40
Overview of MMP Biology and Gene Associations in Human Diseases
Djurić, T., & Živković, M. (2017) · InTech eBooks · doi:10.5772/intechopen.70265 · Cited by 40
Zhang, Y., Fan, X., Chakaravarty, D., Xiang, B., Scannevin, R. H., Huang, Z., Ma, J., Burke, S. L., Karnachi, P., Rhodes, K. J., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.045 · Cited by 39
Potential Clinical Applications of Matrix Metalloproteinase Inhibitors and their Future Prospects
Li, W., Saji, S., Sato, F., Noda, M., & Toi, M. (2013) · The International Journal of Biological Markers · doi:10.5301/jbm.5000026 · Cited by 39
Matrix metalloproteinases in head and neck cancer: current perspectives
Gkouveris, I., Nikitakis, N. G., Aseervatham, J., Rao, N., & Ogbureke, K. U. E. (2017) · Metalloproteinases In Medicine · doi:10.2147/mnm.s105770 · Cited by 37
The discovery of anthranilic acid-based mmp inhibitors. Part 3: incorporation of basic amines
Levin, J. I., Chen, J. M., Du, M. T., Nelson, F. C., Wehr, T. C., DiJoseph, J. F., Killar, L. M., Skala, S., Sung, A., Sharr, M. A., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00601-1 · Cited by 36
Hanessian, S., BouzBouz, S., Boudon, A., Tucker, G. C., & Peyroulan, D. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00259-0 · Cited by 33
Benzodiazepine inhibitors of the MMPs and TACE
Nelson, F. C., Santos, E. D., Levin, J. I., Chen, J., Skotnicki, J. S., DiJoseph, J. F., Sharr, M. A., Sung, A., Killar, L. M., Cowling, R. A., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00633-9 · Cited by 33
Potent “Clicked” MMP2 Inhibitors: Synthesis, Molecular Modeling and Biological Exploration
Zapico, J. M., Serra, P., García-Sanmartín, J., Filipiak, K., Carbajo, R. J., Schott, A. K., Pineda‐Lucena, A., Martínez, A., Martín‐Santamaría, S., de Pascual‐Teresa, B., et al. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00852d · Cited by 33
Mukherjee, A., Adhikari, N., & Jha, T. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.052 · Cited by 33
Self-citationMaquoi, E., Munaut, C., Colige, A., Lambert, C. A., Frankenne, F., Noël, A., Grams, F., Krell, H., & Foidart, J. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5489 · Cited by 32
Progress towards water-soluble triazole-based selective MMP-2 inhibitors
Fabre, B., Filipiak, K., Zapico, J. M., Díaz, N., Carbajo, R. J., Schott, A. K., Martinez‐Alcazar, M. P., Suárez, D., Pineda‐Lucena, A., Ramos, A., et al. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob41046c · Cited by 32
Selivanova, S. V., Stellfeld, T., Heinrich, T. K., Herde, A. M., Krämer, S. D., Schubiger, P. A., Schibli, R., Ametamey, S. M., Vos, B., Meding, J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400156p · Cited by 32
Gao, Q., Wang, Y., Hou, J., Yao, Q., & Zhang, J. (2017) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-017-0028-3 · Cited by 28
Vu, H. T., Hoang, T. X., & Kim, J. Y. (2018) · BioMed Research International · doi:10.1155/2018/5971080 · Cited by 28
Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors
Tuccinardi, T., Nuti, E., Ortore, G., Rossello, A., Avramova, S. I., & Martinelli, A. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.004 · Cited by 26
Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors
Baxter, A. D., Bhogal, R., Bird, J., Keily, J. F., Manallack, D. T., Montana, J. G., Owen, D. A., Pitt, W. R., Watson, R. J., & Wills, R. E. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00259-1 · Cited by 22
Yang, S., Scannevin, R. H., Wang, B., Burke, S. L., Huang, Z., Karnachi, P., Wilson, L. J., Rhodes, K. J., Lagu, B. R., & Murray, W. V. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.129 · Cited by 21
Hou, J., Zou, Q. S., Wang, Y., Gao, Q., Yao, W., Yao, Q., & Zhang, J. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1509019 · Cited by 20
New in Vivo Compatible Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitors
Beutel, B., Song, J., Konken, C. P., Korpos, É., Schinor, B., Gerwien, H., Vidyadharan, R., Burmeister, M., Li, L., Haufe, G., et al. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00618 · Cited by 20
Adhikari, N., Amin, S. A., Saha, A., & Jha, T. (2017) · Structural Chemistry · doi:10.1007/s11224-017-1028-6 · Cited by 16
Self-citationCollagenases and gelatinases and their inhibitors as anticancer agents
Adhikari, N., Amin, S. A., & Jha, T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818168-3.00010-3 · Cited by 10
Self-citation
Cited by
Multifunctional intracellular matrix metalloproteinases: implications in disease
Bassiouni, W., Ali, M. A. M., & Schulz, R. (2021) · The FEBS Journal · doi:10.1111/febs.15701 · Cited by 377
Targeting the tumor stroma for cancer therapy
Xu, M., Zhang, T., Xia, R., Wei, Y., & Wei, X. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01670-1 · Cited by 319
Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis
Li, S., Pritchard, D. M., & Yu, L.-G. (2022) · Cancers · doi:10.3390/cancers14133263 · Cited by 82
Pizani, R. S., Viganó, J., de Souza Mesquita, L. M., Contieri, L. S., Sanches, V. L., Chaves, J. O., Souza, M. C., da Silva, L. C., & Rostagno, M. A. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.07.001 · Cited by 57
The role of matrix metalloproteinases in liver function and disease
Mitropoulou, G., Kompoura, V., Saffioti, F., & Mavroeidis, V. K. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl27127 · Cited by 14
Metadata
- Authors
- Mondal, S., Adhikari, N., Banerjee, S., Amin, S. A., & Jha, T.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 194
- Pages
- 112260
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W3011825303
- Cited by
- 556
- References
- 118
- FWCI
- 20.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.